Status | Study |
Not yet recruiting |
Study Name: Prevalence of Amyloidosis and Carpal Tunnel Condition: Amyloid Neuropathy, Carpal Tunnel Date: 2014-04-01 |
Active, not recruiting |
Study Name: APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis Condition: TTR-mediated Amyloidosis Amyloidosis, Hereditary Date: 2013-10-09 Interventions: Drug: patisiran (ALN-TTR02) ad |
Active, not recruiting |
Study Name: Efficacy and Safety of IONIS-TTR Rx in Familial Amyloid Polyneuropathy Condition: FAP Familial Amyloid Polyneuropathy Date: 2012-11-27 Interventions: Drug: IONIS-TTR Rx 300 mg IONI |
Recruiting |
Study Name: Screening for the Transthyretin-Related Familial Amyloidotic Small Fiber Polyneuropathy Condition: Polyneuropathies Amyloidosis Amyloid Date: 2012-10-09 |
Active, not recruiting |
Study Name: Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy Condition: Cardiac Amyloidosis Amyloidosis in Transthyretin (TTR) Hyp Date: 2012-06-13 |
Completed |
Study Name: Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers Condition: Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) Tra Date: 2012-05-21 Interventions: Other: No drug No drug. |
Completed |
Study Name: Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis Condition: Transthyretin Amyloidosis Cardiomyopathy Date: 2012-04-19 Interventions: Drug: Doxycycline 200 mg/day ( |
Completed |
Study Name: The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin Condition: Transthyretin Familial Amyloid Polyneuropathy Date: 2011-09-13 Interventions: Drug: tafamidis tafamidis meglumine 20 mg QD Other N |
Completed |
Study Name: The Effect of Diflunisal on Familial Transthyretin Amyloidosis Condition: Amyloidosis Date: 2011-09-09 Interventions: Drug: Diflunisal Film-coated tablet, 250 mg twice daily, orally for approximately 2 years |
Completed |
Study Name: Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin Amyloidosis Condition: Transthyretin Amyloidosis Date: 2010-07-27 Interventions: Drug: Doxycycline + Tauroursodeoxycholic acid doxycycline 100 mg twice a day for 12 months; tauroursodeo |